mRNA COVID-19 Vaccines-Facts and Hypotheses on Fragmentation and Encapsulation

Jacques Demongeot1, Cécile Fougère1

  • 1AGEIS & Telecom4Health, Faculty of Medicine, University Grenoble Alpes, 38700 La Tronche, France.

Vaccines
|January 21, 2023
PubMed
Abstract

Insights

Messenger RNA (mRNA) vaccines, initially developed for influenza, have been adapted for SARS-CoV-2. Research suggests potential mRNA fragmentation and biodistribution issues with lipid nanoparticles (LNPs), necessitating personalized vaccine strategies.

Area of Science:

  • Vaccinology
  • Molecular Biology
  • Virology

Background:

  • Messenger RNA (mRNA) vaccine technology originated from influenza research approximately 30 years ago.
  • Early mRNA vaccines involved encapsulating mRNA encoding viral proteins within lipid particles.
  • Current mRNA vaccines for SARS-CoV-2 utilize modified mRNA encoding the S protein.

Purpose of the Study:

  • To investigate the modifications of mRNA encoding the S protein for anti-SARS-CoV-2 vaccination.
  • To assess the theoretical possibility of mRNA fragmentation and its potential impact on cellular biosynthesis.
  • To analyze the role of liposomal nanoparticles (LNPs) in mRNA vaccine biodistribution and potential adverse effects.

Main Methods:

  • Analysis of genetic and epidemiologic databases.
  • Theoretical modeling of mRNA fragmentation and its biological consequences.
  • Evaluation of LNP characteristics and their influence on mRNA biodistribution.

Main Results:

  • Demonstrated the theoretical possibility of mRNA fragmentation into small RNA sequences.
  • Identified potential inhibition of essential biosynthetic pathways, such as beta-globin production, due to fragmented mRNA.
  • Highlighted concerns regarding mRNA biodistribution influenced by LNPs.

Conclusions:

  • Discussed the plausibility of mRNA fragmentation in vaccines.
  • Emphasized the need for improved LNPs for personalized vaccine administration to mitigate adverse effects.
  • Recommended adapting vaccine mRNA to less mutated viral proteins and tailoring administration for at-risk patient groups.

Related Concept Videos

Conjugated Proteins02:50

Conjugated Proteins

Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.4K
Vaccinations01:51

Vaccinations

Overview
45.1K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
116
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.2K
Viral Structure00:56

Viral Structure

Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
63.0K